Fertility Services Market by Procedure (IVF with ICSI, Surrogacy, IVF without ICSI, IUI and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Update Available On-Demand
|
LI_184557
|
Pages: 166
|
Feb
2018 |
5434 Views
|
|
|
|
Author(s) :
Sohail Shaikh & Onkar Sumant
|
Tables: 60
|
Charts: 21
|
Formats*:
|
|
Fertility Services Market Overview:
The Global Fertility Services Market was valued at $16,761 million in 2016, and is estimated to reach at $30,964 million by 2023, registering a CAGR of 9.3% from 2017 to 2023. Fertility services involve different procedures utilized to treat genetic and fertility issues and assist with conception. These services include different assisted reproductive technology (ART) methods, helping couples or single parents around the world.
Surge in prevalence of delayed pregnancies and growth in infertility rates drive the fertility services industry. In addition, availability of latest medical technologies in IVF devices throughout the world, is expected to fuel the market growth.
The fertility services market is segmented based on procedure, service, end user, and region. Based on procedure, the market is divided into in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), and others. Based on service, the fertility services market is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. Similarly, by end user this market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. Based on region, the fertility services market size is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The fertility service market is expected to witness a moderate growth during the forecast period, owing to the rise in adoption of fertility services due to surge in disposable income of population. Furthermore, health insurance portability and rise in advertising and marketing of medical facilities to promote artificial reproduction are anticipated to augment the market growth. However, costs associated with fertility services and reimbursement issues related to fresh IVF cycles are expected to hamper the fertility services industry.
Get more information on this report : Request Sample Pages
With respect to fertility services market share, fertility clinics occupied the largest share in the fertility services market owing to the availability and accessibility of different services related to IVF such as infertility treatment, IVF programs, egg donation, intracytoplasmic sperm injection (ICSI), intra-cytoplasmic morphologically selected sperm injection (IMSI), and others in these clinics.
Get more information on this report : Request Sample Pages
Asia-Pacific possesses high market potential for the growth of the fertility services market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development.
The report provides extensive competitive analysis and profiles of key market players, such as Apollo Hospitals Enterprise Ltd, Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., and Xytex Cryo International The other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, LifeGlobal Group, and IVFtech ApS.
Key Benefits for Stakeholders
- This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
- Market estimations are based on comprehensive analysis of the key developments in the industry.
- In-depth analysis based on region assists to understand the regional market and the strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Fertility Services Market Key Segments:
By Procedure
- IVF with ICSI
- Surrogacy
- IVF without ICSI
- IUI
- Others (GIFT and ZIFT)
By Service
- Fresh Non-Donor
- Frozen Non-Donor
- Egg and Embryo Banking
- Fresh Donor
- Frozen Donor
By End User
- Fertility clinics
- Hospitals
- Surgical centres
- Clinical research institutes
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Winning Strategies, By Company, 2015-2017
3.3. PORTER’S FIVE FORCE ANALYSIS
3.4. GOVERNMENT REGULATIONS
3.4.1. U.S.
3.4.1. Europe
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Continuous decline in fertility rates
3.6.1.2. Delayed pregnancies in women
3.6.1.3. Technological advancements with respect to fertility treatment
3.6.2. Restraints
3.6.2.1. High treatment costs of ARTs in developed countries
3.6.2.2. Inadequate reimbursement policies
3.6.3. Opportunity
3.6.3.1. Rise in fertility tourism
CHAPTER 4 FERTILITY SERVICES MARKET, BY PROCEDURE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. IVF WITH ICSI
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. IUI
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. IVF WITHOUT ICSI
4.4.1. Key market trends growth factors, and opportunities
4.4.2. Market size and forecast
4.5. SURROGACY
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.6. OTHERS
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
CHAPTER 5 FERTILITY SERVICES MARKET, BY SERVICE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. FRESH NON-DONOR
5.2.1. Market size and forecast
5.3. FROZEN NON-DONOR
5.3.1. Market size and forecast
5.4. EGG AND EMBRYO BANKING
5.4.1. Market size and forecast
5.5. FRESH DONOR
5.5.1. Market size and forecast
5.6. FROZEN DONOR
5.6.1. Market size and forecast
CHAPTER 6 FERTILITY SERVICES MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. FERTILITY CLINICS
6.2.1. Market size and forecast
6.3. HOSPITALS
6.3.1. Market size and forecast
6.4. SURGICAL CENTERS
6.4.1. Market size and forecast
6.5. CLINICAL RESEARCH INSTITUTES
6.5.1. Market size and forecast
CHAPTER 7 FERTILITY SERVICES MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by service
7.2.5. Market size and forecast, by end user
7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada size and forecast
7.2.5.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by service
7.3.5. Market size and forecast, by end user
7.3.5.1. Germany market size and forecast
7.3.5.2. France market size and forecast
7.3.5.3. UK market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by service
7.4.5. Market size and forecast, by end user
7.4.5.1. Japan market size and forecast
7.4.5.2. India market size and forecast
7.4.5.3. China market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Taiwan market size and forecast
7.4.5.7. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by service
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil market size and forecast
7.5.5.2. Turkey market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. South Africa market size and forecast
7.5.5.5. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. APOLLO HOSPITALS ENTERPRISE LTD.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CARE FERTILITY GROUP
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Key strategic moves and developments
8.3. CAROLINAS FERTILITY INSTITUTE
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.4. GENEA LIMITED
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. THE JOHNS HOPKINS HEALTH SYSTEM CORP.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. MEDICOVER GROUP
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. MONASH IVF GROUP
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. OVASCIENCE INC.
8.8.1. Company overview
8.8.2. Product portfolio
8.8.3. Business performance
8.8.4. Key strategic moves and developments
8.9. PROGYNY INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Key strategic moves and developments
8.10. XYTEX CRYO INTERNATIONAL
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Product portfolio
LIST OF TABLES
TABLE 1. KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW
TABLE 2. INSURANCE COVERAGE FOR COUNTRIES
TABLE 3. FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2016-2023 ($MILLION)
TABLE 4. FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2016-2023 ($MILLION)
TABLE 5. FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2016-2023 ($MILLION)
TABLE 6. FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2016-2023 ($MILLION)
TABLE 7. FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2016-2023 ($MILLION)
TABLE 9. FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2016-2023 ($MILLION)
TABLE 10. FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2016-2023 ($MILLION)
TABLE 11. FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2016-2023 ($MILLION)
TABLE 12. FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2016-2023 ($MILLION)
TABLE 13. FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 15. FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. FERTILITY SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 26. EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2016-2023 ($MILLION)
TABLE 27. EUROPE FERTILITY SERVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 34. LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2016-2023 ($MILLION)
TABLE 35. LAMEA FERTILITY SERVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. APOLLO HOSPITALS: COMPANY SNAPSHOT
TABLE 37. APOLLO HOSPITALS: OPERATING SEGMENTS
TABLE 38. APOLLO HOSPITALS: PRODUCT PORTFOLIO
TABLE 39. CARE FERTILITY GROUP: COMPANY SNAPSHOT
TABLE 40. CARE FERTILITY GROUP: PRODUCT PORTFOLIO
TABLE 41. CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT
TABLE 42. CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO
TABLE 43. GENEA LIMITED: COMPANY SNAPSHOT
TABLE 44. GENEA LIMITED: OPERATING SEGMENTS
TABLE 45. GENEA LIMITED: PRODUCT PORTFOLIO
TABLE 46. JHHS: COMPANY SNAPSHOT
TABLE 47. JHHS: OPERATING SEGMENTS
TABLE 48. JHHS: PRODUCT PORTFOLIO
TABLE 49. MEDICOVER: COMPANY SNAPSHOT
TABLE 50. MEDICOVER: OPERATING SEGMENTS
TABLE 51. MEDICOVER: PRODUCT PORTFOLIO
TABLE 52. MVF: COMPANY SNAPSHOT
TABLE 53. MVF: OPERATING SEGMENTS
TABLE 54. MVF: PRODUCT PORTFOLIO
TABLE 55. OVASCIENCE: COMPANY SNAPSHOT
TABLE 56. OVASCIENCE: PRODUCT PORTFOLIO
TABLE 57. PROGYNY: COMPANY SNAPSHOT
TABLE 58. PROGYNY: PRODUCT PORTFOLIO
TABLE 59. XYTEX: COMPANY SNAPSHOT
TABLE 60. XYTEX: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. FERTILITY SERVICES MARKET: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES, BY YEAR, 2015-2017
FIGURE 4. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2017 (%)
FIGURE 5. HIGH BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF SUBSTITUTION
FIGURE 8. MODERATE THREAT OF NEW ENTRANT
FIGURE 9. MODERATE COMPETITIVE RIVALRY
FIGURE 10. CDC (2017) DATA RELATED TO DELAYED PREGNANCY: KEY TAKEAWAYS
FIGURE 11. FERTILITY SERVICES MARKET: PROCEDURE SEGMENTATION
FIGURE 12. GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
FIGURE 13. ESTIMATED NUMBER OF BIRTHS PER WOMAN (GLOBAL FERTILITY RATE)
FIGURE 14. APOLLO HOSPITALS: NET SALES, 2015-2017 ($MILLION)
FIGURE 15. APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 16. MEDICOVER: NET SALES, 2015-2017 ($MILLION)
FIGURE 17. MEDICOVER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 18. MEDICOVER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 19. MVF: NET SALES, 2015-2017 ($MILLION)
FIGURE 20. MVF: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 21. OVASCIENCE: NET SALES, 2015-2017 ($MILLION)
Fertility services refer to the different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally. These services are availed to treat infertility. The different fertility procedures include in-vitro fertilization (IVF), intra-uterine insemination (IUI), surrogacy, and others. IVF is one of the most widely known fertility services offered by fertility clinics, this treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention
The fertility services market is anticipated to witness considerable growth in future owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in ART procedures, surge in male infertility, and increased occurrences of gamete donations. Moreover, an increase in awareness regarding in vitro fertilization, surge in popularity of medical & fertility tourism coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth.
However, inadequate reimbursement policies associated fertility procedures are anticipated to impede the market growth in the forecast period. Moreover, growth in interest of single parents as well as same-sex couples in experiencing parenthood through artificial reproductive technology (ART), and affordable fertility treatment offered in emerging markets such as India is expected to present lucrative opportunities for market expansion. At present, the fertility clinics are the largest end users of fertility services, followed by hospitals, surgical centers and clinical research institutes. The surgical center end user segment is expected to exhibit the highest growth rate throughout the forecast period.
Download Sample
Purchase Full Report of
Fertility Services Market- Global Opportunity Analysis and Industry Forecast, 2017-2023
- Online Only
- $3,456
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,840
- Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,370
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,450
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $8,995
- Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"Fertility Services Market"
Purchase Enquiry